Scientific Opinion on the substantiation of health claims related to
Lactobacillus johnsonii BFE 6128 and “natural defences/immune system”
(ID 990) and “skin health” (ID 991) pursuant to Article 13(1) of Regulation
(EC) No 1924/2006[sup]1[/sup]
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)2, 3
European Food Safety Authority (EFSA), Parma, Italy
Słowa kluczowe:
Lactobacillus johnsonii BFE 6128
health claims
immune system
skin
1. Charakterystyka żywności / składnika
The food constituent that is the subject of the health claim is Lactobacillus johnsonii BFE 6128.
The identity and characteristics of the strain Lactobacillus johnsonii BFE 6128 have been determined using phenotypic and genotypic methods (Vizoso Pinto et al., 2006).
No indication of the deposit of the strain in an internationally recognised culture collection was found in the information provided or in the literature.
The Panel considers that the food constituent, Lactobacillus johnsonii BFE 6128, which is the subject of the health claim, is sufficiently characterised.
2. Znaczenie oświadczenia dla zdrowia człowieka
2.1. Naturalne funkcje układu odpornościowego (ID 990)
The claimed effect is “natural defences/immune system”. The Panel assumes that the target population is the general population.
The claimed effect is not sufficiently defined and no further details were given in the proposed wording or the clarifications provided by Member States. Given the multiple roles of the immune system, the specific aspect of immune function that is the subject of the claim needs to be specified, but it has not been indicated in the information provided.
The Panel considers that the claimed effect is general and non-specific, and does not refer to any specific health claim as required by Regulation (EC) No 1924/2006.
2.2. Zdrowie skóry (ID 991)
The claimed effect is “skin health”. The Panel assumes that the target population is the general population.
The claimed effect is not sufficiently defined and no further details were given in the proposed wording or the clarifications provided by Member States.
The Panel considers that the claimed effect is general and non-specific, and does not refer to any specific health claim as required by Regulation (EC) No 1924/2006.
Wnioski
On the basis of the data presented, the Panel concludes that:
The food constituent, Lactobacillus johnsonii BFE 6128, which is the subject of the health claim, is sufficiently characterised.
“Natural defences/immune system” (ID 990)
The claimed effect is “natural defences/immune system”. The target population is assumed to be the general population.
The claimed effect is general and non-specific, and does not refer to any specific health claim as required by Regulation (EC) No 1924/2006.
“Skin health” (ID 991)
The claimed effect is “skin health”. The target population is assumed to be the general population.
The claimed effect is general and non-specific, and does not refer to any specific health claim as required by Regulation (EC) No 1924/2006.
